Amryt Pharma Management
Management criteria checks 3/4
Amryt Pharma's CEO is Joe Wiley, appointed in Jan 2015, has a tenure of 8.25 years. total yearly compensation is $1.72M, comprised of 43.4% salary and 56.6% bonuses, including company stock and options. directly owns 1.1% of the company’s shares, worth $10.36M. The average tenure of the management team and the board of directors is 3.3 years and 3.6 years respectively.
Key information
Joe Wiley
Chief executive officer
US$1.7m
Total compensation
CEO salary percentage | 43.4% |
CEO tenure | 8.3yrs |
CEO ownership | 1.1% |
Management average tenure | 3.3yrs |
Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Amryt gets EMA panel nod for Mycapssa to retain orphan drug status in EU
Oct 18Amryt growth hormone disorder drug Mycapssa gets EMA panel nod for EU approval
Sep 16Amryt gets British marketing approval & orphan drug designation for rare skin disease gel
Sep 08Amryt stock rises 11% on FDA orphan drug status for Mycapssa for rare tumor condition
Jul 14Amryt's Filsuvez gets approval in EU to treat rare skin disorder
Jun 23Amryt Pharma: Advancing Novel Treatments For Rare And Debilitating Conditions
Dec 09Chiasma surges on merger agreement with Amryt
May 05Amryt and Medison Pharma inks distribution deal for Juxtapid, Lojuxta and Myalept
Feb 04Amryt's AP103 an Orphan Drug in U.S. for skin blistering disorder
Dec 23Amryt Group's Lojuxta receives marketing approval in Brazil
Dec 09CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$790k |
Jun 30 2022 | n/a | n/a | US$3m |
Mar 31 2022 | n/a | n/a | US$3m |
Dec 31 2021 | US$2m | US$747k | US$1m |
Sep 30 2021 | n/a | n/a | -US$88m |
Jun 30 2021 | n/a | n/a | -US$81m |
Mar 31 2021 | n/a | n/a | -US$92m |
Dec 31 2020 | US$2m | US$727k | -US$105m |
Sep 30 2020 | n/a | n/a | -US$87m |
Jun 30 2020 | n/a | n/a | -US$92m |
Mar 31 2020 | n/a | n/a | -US$87m |
Dec 31 2019 | US$1m | US$588k | -US$63m |
Compensation vs Market: Joe's total compensation ($USD1.72M) is below average for companies of similar size in the US market ($USD3.42M).
Compensation vs Earnings: Joe's compensation has increased whilst the company is unprofitable.
CEO
Joe Wiley (51 yo)
8.3yrs
Tenure
US$1,720,000
Compensation
Dr. Joseph A. Wiley, also known as Joe, M.D. was the Founder of Amryt Pharma plc and serves as its Chief Executive Officer since 2015. He has been a Director at Amryt Pharma plc since April 19, 2016. Dr. W...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 8.3yrs | US$1.72m | 1.1% $ 10.4m | |
CFO, COO & Company Secretary | 8.3yrs | US$939.00k | 0.51% $ 4.8m | |
Chief Compliance Officer | 2.3yrs | no data | no data | |
General Counsel | 5.6yrs | no data | no data | |
Head of Marketing & Head of APAC | 4.3yrs | no data | no data | |
Head of Human Resources | no data | no data | no data | |
Head of Medical Affairs | no data | no data | no data | |
President of Americas | 2yrs | no data | no data | |
Chief Medical Officer | less than a year | no data | no data | |
President of EMEA Region | less than a year | no data | no data |
3.3yrs
Average Tenure
54.5yo
Average Age
Experienced Management: AMYT's management team is considered experienced (3.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 7yrs | US$1.72m | 1.1% $ 10.4m | |
Independent Non-Executive Director | 3.6yrs | US$88.00k | 0.023% $ 220.5k | |
Independent Non-Executive Director | 3.6yrs | US$58.00k | 0.0070% $ 66.1k | |
Independent Non-Executive Director | 3.6yrs | US$60.00k | 0.0078% $ 73.5k | |
Independent Non-Executive Director | 3.6yrs | US$80.00k | 0% $ 0 | |
Independent Non-Executive Chairman of the Board | 7yrs | US$88.00k | 0.61% $ 5.8m | |
Independent Non-Executive Director | 1.7yrs | US$20.00k | 0% $ 0 | |
Independent Non-Executive Director | 3.6yrs | US$65.00k | 0.031% $ 294.0k | |
Independent Non-Executive Director | 1.7yrs | US$20.00k | 0% $ 0 |
3.6yrs
Average Tenure
59yo
Average Age
Experienced Board: AMYT's board of directors are considered experienced (3.6 years average tenure).